Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
08 nov. 2023 08h19 HE
|
Biomerica, Inc.
Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rolloutVeteran Vice President of Sales and National...
REPEAT - Biomerica Reports First Quarter 2024 Financial Results
13 oct. 2023 13h10 HE
|
Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024
Biomerica Reports First Quarter 2024 Financial Results
13 oct. 2023 06h39 HE
|
Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024
Viral Gastroenteritis Global Market Report 2023: A $7.68 Billion Market by 2027 - Product Innovation and FDA Approvals Fuel Growth to 2032
10 oct. 2023 07h18 HE
|
Research and Markets
Dublin, Oct. 10, 2023 (GLOBE NEWSWIRE) -- The "Viral Gastroenteritis Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global viral gastroenteritis market is...
Novozymes OneHealth and Juneyao Health announced a strategic partnership at 14th ACN
21 sept. 2023 01h23 HE
|
Novozymes OneHealth
Chengdu, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The 14th Asian Congress of Nutrition(ACN), held in Chengdu, China from September 14th to 17th, 2023 brought together experts and enthusiasts in the field...
Constipation Treatment Market to Reach $10.1 Billion by 2032, exhibiting a CAGR of 5.6% from 2023 to 2032: Allied Market Research
07 sept. 2023 09h00 HE
|
Allied Market Research
New Castle, Delaware, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Constipation treatment Market by Product Type (Mu-Opioid Receptor Antagonists, Laxative,...
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
28 août 2023 08h19 HE
|
Biomerica, Inc.
Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian...
Biomerica Reports Fiscal 2023 Year End Results
25 août 2023 17h00 HE
|
Biomerica, Inc.
Revenues excluding Covid test sales increased 15% for fiscal 2023 vs fiscal 2022 Successfully completed inFoods® IBS pilot program with one of the largest Gastrointestinal physician groups in the US ...
Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
21 juin 2023 08h19 HE
|
Biomerica, Inc.
Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using Personal Medical DataThe Patent further describes Algorithms to help Determine Safety Levels of Food...
Global Gastrointestinal Partnering Analysis Report 2023: Deal Trends, Players and Financials for Over 480 Deals Signed Since 2016 by the World's Leading Life Science Companies
31 mai 2023 03h13 HE
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Gastrointestinal Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.Global...